Cardiovascular and liver disease are main contributors to mortality in people with HIV (PWH). In HIV-uninfected patients, non-alcoholic fatty liver disease (NAFLD) is associated with incident metabolic complications. We investigated the effect of NAFLD on development of metabolic comorbidities in PWH.
Non-alcoholic fatty liver disease predicts development of metabolic comorbidities in HIV-infected patients / T, K., M, M., R, S., N, K., Falutz, J., Guaraldi, G., Lebouche, B., M B, K., P, W., M, D., P, G., G, S.. - In: THE JOURNAL OF INFECTIOUS DISEASES. - ISSN 0022-1899. - 222:5(2020), pp. 787-797. [10.1093/infdis/jiaa170]
Non-alcoholic fatty liver disease predicts development of metabolic comorbidities in HIV-infected patients
G, Guaraldi;
2020
Abstract
Cardiovascular and liver disease are main contributors to mortality in people with HIV (PWH). In HIV-uninfected patients, non-alcoholic fatty liver disease (NAFLD) is associated with incident metabolic complications. We investigated the effect of NAFLD on development of metabolic comorbidities in PWH.
| File | Dimensione | Formato | |
|---|---|---|---|
|
jiaa170.pdf
Open access
Tipologia:
VOR - Versione pubblicata dall'editore
Dimensione
3.06 MB
Formato
Adobe PDF
|
3.06 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
